Financial results - BSD PHARMACEUTICALS SRL

Financial Summary - Bsd Pharmaceuticals Srl
Unique identification code: 37951269
Registration number: J2017000525376
Nace: 4646
Sales - Ron
1.495.749
Net Profit - Ron
-7.118
Employees
7
Open Account
Company Bsd Pharmaceuticals Srl with Fiscal Code 37951269 recorded a turnover of 2024 of 1.495.749, with a net profit of -7.118 and having an average number of employees of 7. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Bsd Pharmaceuticals Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 0 87 391 22.378 1.216 516.555 2.316.087 1.495.749
Total Income - EUR - - 0 103 631 22.379 1.216 516.555 2.319.162 1.495.959
Total Expenses - EUR - - 26.234 77.576 70.423 85.052 92.525 548.753 2.296.612 1.503.077
Gross Profit/Loss - EUR - - -26.234 -77.473 -69.792 -62.673 -91.309 -32.198 22.551 -7.118
Net Profit/Loss - EUR - - -26.234 -77.474 -69.798 -62.880 -91.321 -36.079 14.192 -7.118
Employees - - 5 7 5 7 6 6 6 7
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -35.1%, from 2.316.087 euro in the year 2023, to 1.495.749 euro in 2024. The Net Profit decreased by -14.113 euro, from 14.192 euro in 2023, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Bsd Pharmaceuticals Srl

Rating financiar

Financial Rating -
BSD PHARMACEUTICALS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Bsd Pharmaceuticals Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bsd Pharmaceuticals Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Bsd Pharmaceuticals Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bsd Pharmaceuticals Srl - CUI 37951269

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 4.111 21.422 15.018 10.090 2.958 1.621 4.227 25.251
Current Assets - - 7.446 11.835 16.838 23.976 9.780 100.008 74.525 133.902
Inventories - - 2.612 2.575 3.664 3.485 4.699 76.154 2.093 30.488
Receivables - - 2.542 8.969 12.536 14.931 3.206 16.739 70.124 94.487
Cash - - 2.292 292 639 5.560 1.876 7.115 2.309 8.927
Shareholders Funds - - -26.191 -103.184 -170.984 -230.623 -316.830 -353.892 -338.627 -344.235
Social Capital - - 44 43 42 41 40 41 40 40
Debts - - 37.747 136.441 202.840 264.689 329.568 455.520 417.379 503.388
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 133.902 euro in 2024 which includes Inventories of 30.488 euro, Receivables of 94.487 euro and cash availability of 8.927 euro.
The company's Equity was valued at -344.235 euro, while total Liabilities amounted to 503.388 euro. Equity decreased by -7.501 euro, from -338.627 euro in 2023, to -344.235 in 2024.

Risk Reports Prices

Reviews - Bsd Pharmaceuticals Srl

Comments - Bsd Pharmaceuticals Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.